The Prevalence of Ectopic Gestation: A Five-Year Study of 1273 Cases

Abstract

Objective

This study aims to investigate the prevalence, related risk factors, manifestations, and management of ectopic pregnancy in the first hospital of the Jilin University over a five-year period.

Methods

A retrospective study of ectopic pregnancy was conducted in the First Hospital of the Jilin University between January 1, 2010 and December 31, 2014. The results were analyzed using simple descriptive statistics and reported as frequencies and percentages.

Results

The results revealed that out of 16,050 gynecological admissions to the hospital over the five-year period, there were 1273 ectopic pregnancies, with a prevalence rate of 7.93% of all gynecological admissions. The majority of these patients were aged 25–34 y and had a past history of abortion (61%) and uterine cavity surgery (38.6%), and a significant number were nulliparous (549, 43.1%). Bleeding accompanied by abdominal pain were the most common presenting complaints (65.2%). A unilateral salpingectomy was performed for most of these patients.

Conclusion

Ectopic pregnancy had notable morbidity over the five-year period under study, and a history of abortion and uterine cavity surgery were identified as associated risk factors that limited the future reproductive potential of nulliparous women. Therefore, targeted health education campaigns should be conducted in order to enlighten this group of women and the public at large.

Keywords:

• ectopic pregnancy
• risk factors
• fertilized ovum
• fallopian tube
• reproductive accomplishments

Introduction

Ectopic pregnancy (EP) is an abnormal pregnancy in which a fertilized egg is implanted outside the uterine cavity. At least 90% of all EPs are located in the fallopian tube, and 80% of these are located in the ampullary segment of the tube.^1–4 EP occurs in 1–2% of pregnancies and is associated with significant morbidity and mortality. Bleeding from ruptured fallopian tubes resulting from EP remains the most common cause of maternal mortality in the first trimester of pregnancy,^5,6 and any pregnant woman could have an EP.² However, pelvic inflammatory disease is the most common risk factor for EP.⁷ Other risk factors include the use of progesterone-only pills, intrauterine contraceptive devices (IUDs), endometriosis, previous tubal surgery, infertility, previous abortion, and assisted reproductive technology. The diagnosis is made primarily via transvaginal ultrasound (TVS) and supported by quantitative serum human chorionic gonadotropin (hCG). Any woman of reproductive age experiencing abnormal vaginal bleeding with or without abdominal pain is at risk of EP and should be followed closely until a diagnosis is made. It is now widely accepted that in the presence of hCG levels above the discriminatory zone of 1500–2500 IU/L, a normal intrauterine pregnancy (IUP), defined by the existence of a gestational sac, should be visible by TVS. Therefore, the absence of an intrauterine gestational sac when the hCG concentration is above the discriminatory zone implies an abnormal gestation.² As a result of the limited resolution of TVS, not all EPs can be recognized, causing an “unknown location of pregnancy” result after an ultrasound.⁸ The patient’s clinical condition, geographical location, and desire to reproduce and the available facilities all affect the treatment of EPs. Medical management is a safe and effective option in most clinically stable patients. Patients who have failed medical management, or are ineligible for medical management, or present with a ruptured EP or a heterotopic pregnancy are most often managed with excision via laparoscopy or, less commonly, laparotomy.⁹ Areas of active research include decreased time to diagnose EP, risk stratification in women with initial symptoms, and improved time to resolution via medical management. Therefore, it is of great significance to conduct statistical analyses on the disease characteristics of EP from large quantities of clinical data. This paper discusses the prevalence, associated risk factors, manifestations, and management of EP in the First Hospital of the Jilin University.

Materials and Methods

Subject

This retrospective review included patients with EP who were treated at the First Hospital of the Jilin University between January 1, 2010 and December 31, 2014. The medical records of all participants were retrieved from the gynecology department, and during the review process, the confidentiality of patient data was ensured. The study was conducted in accordance with the Declaration of Helsinki (revised in 2013) and was approved by the Ethics Committee of the First Hospital of the Jilin University. All subjects signed informed consent.

Inclusion and Exclusion Criteria

Inclusion criteria: (1) diagnosis of EP, (2) >14 years old, and (3) signed the informed consent. Exclusion criteria: (1) refusal to be hospitalized or (2) incomplete patient data.

Research Methods

According to the clinical protocol, women with pelvic pain and irregular vaginal bleeding following menstrual abnormalities were evaluated. In the absence of an intrauterine fetal sac, a tubal EP was diagnosed when β-hCG did not increase at the expected rate of 66%/48 hours expected of intrauterine pregnancies and a complex or solid adnexal mass was found on ultrasound, and a progesterone level <25 ng/mL was used to support the diagnosis of an abnormal pregnancy. Women with stable hemodynamics received prospective therapy or methotrexate therapy, typically a single-dose regimen, and a single dose of 50 mg/m².

Main Observation Indexes

Primary factors included age, gestational age, marital status, clinical presentation, diagnostic tools used, treatment options, intraoperative survey results, and associated risk factors.

Statistical Analysis

Statistical analysis was performed using the SPSS 22.0 software program (IBM, Chicago, USA). Continuous variables with a normal distribution were expressed as mean ± standard deviation, continuous variables with a non-normal distribution as median (quaternion range [IQR]), and categorical variables as frequency (percentage [%]). For multiple comparisons on continuous data, each value was compared using a one-way method when the data conformed to a normal distribution, and non-parametric tests were used to compare non-normally distributed. Continuous data was tested using the chi-square test. P < 0.05 was considered statistically significant.

Results

General Characteristics

Of the 16,050 gynecological admissions during the five-year period under study, 1273 EPs were observed, with a prevalence rate of 7.93% of all gynecological admissions. The mean age of the study subjects was 30.62 ± 6.19 y, and the incidence of EP in patients aged <20 or >40 y was extremely low (see Table 1).

Table 1 The Age Distribution

Age (Years)	Number of Patients (%)
15–19	28 (2.2)
20–24	187 (14.7)
25–29	364 (28.6)
30–34	344 (27.0)
35–39	235 (18.5)
40–44	102 (8.0)
45–52	13 (1.0)

The Risk Factors

In 156 cases (12.3%), no risk factors were identified, but in the majority of cases, more than one risk factor was identified (see Table 2).

Table 2 The Risk Factors Detected

No.	Risk Factor	N (%)
1	History of PID	342 (26.9)
2	IUD	155 (12.2)
3	Irregular cycles	127 (10)
4	Smoking	29 (2.3)
5	Dysmenorrhea	288 (22.6)
6	History of abortion	777 (61)
7	History of pelvic surgery	483 (37.9)
8	History of uterine cavity surgery	491 (38.6)

Presentation

As shown in Table 3, the first symptoms included bleeding, abdominal pain, bleeding accompanied by abdominal pain, shock, and digestive tract symptoms, but some patients were asymptomatic. The majority of patients (1027, 80.7%) presented with abdominal pain and bleeding, was elicited (931, 73.1%). A significant number of patients (1220, 95.8%) had a history of amenorrhea, and 42 (3.3%) patients were asymptomatic (see Tables 2 and 3).

Table 3 First Symptoms

No.	First Symptoms	N (%)
1	Bleeding	101 (7.9)
2	Abdominal pain	197 (15.5)
3	Asymptomatic	42 (3.3)
4	Bleeding accompanied by abdominal pain	830 (65.2)
5	Shock	83 (6.5)
6	Digestive tract symptom	20 (1.6)

Site of EP

A total of 929 patients had a tubal EP (73%), and other sites included the ovary (29, 2.3%) and abdomen (7, 0.5%). It is noteworthy that 308 patients (24.2%) had no definite EP site, including 299 patients who received medical and expectant treatment and 9 patients who underwent surgery.

The tubal EPs of 720, 64, and 145 patients occurred in the ampullary (77.5%), cornual (6.9%), and isthmic (15.6%) regions, respectively.

Diagnosis

All patients were diagnosed via TVS and quantitative serum hCG (see Table 4). Three patients had normal levels and 1270 had elevated levels (19.80–318,000.00 IU/L; see Table 4).

Table 4 Trans-Vaginal Ultrasound Findings

No.	Findings	N (%)
1	Pseudosac	75 (5.9)
2	Live extrauterine fetus	309 (24.3)
3	Isolated POD fluid	583 (45.8)
4	Complex adnexal mass	968 (76.0)
5	Simple ov cyst	31 (2.4)

Treatment

Patients with EP received surgical (974, 76.5%), medical (223, 17.5%), or expectant (76, 6%) management, and emergency laparotomy with unilateral salpingectomy was the most common surgical intervention. No mortality was recorded over the five years. There was no difference in serum hCG before treatment between the medical and expectant treatment groups, but the serum hCG was significantly higher in the surgical treatment group (see Table 5).

Table 5 Level of Serum HCG (IU/L)

Treatment Group	N	Min	Max	Median	P
Expectant	76	32.54	11,962.00	361.40	0.982
Medical	223	30.40	19,800.00	387.00	0.982
Surgical	974	3.62	318,000.00	1534.75	<0.05

Clinical Features of Patients without Previous Pregnancy or Delivery

A total of 261 patients had no previous history of pregnancy, and the EP occurred in their first pregnancy. When compared with the patients with a history of pregnancy, there was no difference in the location of the EP, history of pelvic inflammation, number of days from when menstruation stopped, first symptoms, treatment plan, or blood hCG level before treatment. A total of 549 (43.1%) patients were nulliparous. When compared with patients with a delivery history, there was no difference in the location of the EP, history of pelvic inflammation, number of days from when menstruation stopped, first symptoms, treatment plan, or blood hCG level before treatment. However, the percentage of patients with a history of pelvic surgery (21.60%) was significantly lower in the nulliparous patients than in those with a history of delivery (P < 0.05).

Discussion

The prevalence of EP was 7.93% among all gynecological admissions. The majority of these patients were aged 25–34 y and had a past history of abortion (61%) and uterine cavity surgery (38.6%), and a significant number were nulliparous (549, 43.1%). Bleeding accompanied by abdominal pain were the most common presenting complaints (65.2%). Unilateral salpingectomy was performed for most of these patients.

In recent years, with the prevalence of early sexual behavior and late childbearing among young people, there has been a lack of correct guidance on healthy reproduction, and the incidence of EP has increased year by year.^10,11 The present study revealed that a significant proportion of nulliparous women have an EP. Hence, the follow-up fertility problems facing these patients are worthy of attention.

Women with an EP often have no identifiable factors. In the present study, 39% of nulliparous patients had a history of abortion, accounting for a greater proportion than those with a history of pelvic inflammatory disease.¹⁰⁻¹⁸ When compared with women who have previously given birth, nulliparous women less often choose IUDs and oral contraceptives as contraceptive measures, and most of them use condoms, emergency contraceptives, and other measures. This increases the risk of contraceptive failure in these women.¹⁹ The incidence of abortion as a remedy for contraceptive failure is also relatively high in nulliparous women. Chronic infection may occur after an abortion or drug-induced abortion, or inflammatory infection may occur due to excessive vaginal bleeding and residual embryonic tissue, which may lead to tubal peristalsis disorder or lumen obstruction and could increase the risk of an EP.

EP has a wide range of clinical manifestations in women, ranging from being asymptomatic to experiencing severe circulatory failure. Unilateral abdominal pain with vaginal bleeding is often indicative of EP. Therefore, investigation via TVS is required for women of all reproductive ages with risk factors for EP. Non-gynecological symptoms, such as diarrhea, vomiting, or dizziness, may be most noticeable, but may not initially lead to a pregnancy test being conducted at the first evaluation, which may cause women to seek other healthcare services, such as medical or general surgical services.

In modern practice, the diagnosis of EP is based on the positive visualization of an additional uterine mass on TVS²⁰ rather than the absence of an intrauterine gestational sac. At the first consultation, TVS had a sensitivity of 73.9–74.7% for detecting EPs, and in subsequent consultations, the overall sensitivity of TVS was 87–99% and the specificity was 94–99%.^21,22 It is also important not to underestimate the psychological trauma associated with EP and the impact on future fertility.

When possible, an endoscopic approach is the desired route of access for ectopic pregnancies.There have clear advantages of the minimally invasive approach of laparoscopy for tubal pregnancies. These advantages include decreased operative time, a lower risk of postoperative adhesions, shorter inpatient stays, and an accelerated shorter return to activities of daily life as well as work. In this study, some patients with more abdominal bleeding and unstable vital signs underwent laparotomy. Most tubal ectopic pregnancies are located in the ampullary portion of the fallopian tube. For ectopic pregnancies located in the isthmic section of the tube, a partial or complete salpingectomy is recommended on the basis of concerns about the trophoblast infiltrating the tubal wall, with the risk of significant bleeding and low postoperative patency rates with conservative surgery.²³

Limitations

This was a single-center trial, the sample size was small, and the clinical follow-up was short. Therefore, future studies are required to observe the clinical long-term prognosis of patients who have experienced an EP.

Conclusion

Over the past five years, EP has resulted in notable morbidity. A previous history of abortion and uterine cavity surgery were identified as the associated risk factors that limited the future reproductive potential of nulliparous women. Therefore, targeted health education campaigns should be created to enlighten this group of women and the public at large.

Ethics Approval and Consent to Participate

The study was conducted in accordance with the Declaration of Helsinki (as was revised in 2013). The study was approved by Ethics Committee of the First Hospital of Jilin University. All subjects signed informed consent, and a legal guardian of patients under 18 years of age provided informed consent.

Acknowledgments

We are particularly grateful to all the people who have given us help on our article.

Disclosure

The authors declare that they have no competing interests.

Additional information

Funding

There is no funding to report.